12,13-Epoxy-ll-hydroxy-9-octadecenoic Acid, 4,5-Epoxy-N-acetylsphingosine, Human Liver Microsomes Transformation of 12,13-epoxy-ll-hydroxy-9-octadecenoic acid and 4,5-epoxy-N-acetylsphingosine by addition of porcine liver homogenate and human liver microsomes, respec tively was investigated. Both epoxides were converted to corresponding dioles by porcine liver homogenate, but not by human liver microsomes, suggesting location of the hydrolyzing enzymes not in the microsomes, but within the cell wall.
Introduction
Cell injury activates degrading enzymes, for in stance lipases -which cleave phospholipids (Parthasarathy et al, 1985) -and lipoxygenases which transform thus liberated polyunsaturated fatty acids (PUFAs) into lipid hydroperoxides (LOOHs, Wills, 1966) .
In the course of lipid peroxidation (LPO) pro cesses linoleic acid is transform ed to cis/trans-isomeric-9-hydroperoxy-10,12-octadecadienoic acids (9-HPODEs) and 13-hydroperoxy-9,ll-octadecadienoic acids (13-HPODEs, Dolev et al., 1967) . In a biological surrounding H PO D Es are readily re duced to corresponding hydroxy compounds (Christophersen, 1968) , but also undergo -in presence of iron ions -a cleavage to LO* radicals (Gardner, 1989) . Iron ions are generated by suici dal inhibition of lipoxygenase (Fuchs and Spiteller, 2000) . LO* radicals are further transform ed to ep-Epoxides are generated not only by intramolec ular reactions by decomposition of hydroperox ides derived from arachidonic acid and linoleic acid but also by intermolecular reaction by action of double bonds with peroxy radicals (Spiteller, 1998) .
Results

Preparation o f liver homogenate
Porcine livers were removed immediately after slaughter, and transferred in an ice box to the lab oratory where they were homogenized instantly. Homogenates were incubated with the epoxides.
Scheme 2. Formation of 12,13-epoxy-9-octadecenoic acid by epoxidation of linoleic acid.
For instance, peroxy radicals transform linoleic acid and linolenic acid to a variety of epoxides, known as leukotoxines (Ozawa, 1986) . They also react with cholesterol to generate cholesterol ep oxide, detected in atherosclerotic plaques (Smith et al., 1980; Watabe et al., 1982) . Many epoxides are toxic. As a consequence epoxides should be removed as fast as possible from biological sys tems.
In order to investigate the fate of epoxides in biological systems we offered 12,13-epoxy-ll-hydroxy-9-octadecenoic acid, a product formed by conversion of HPODEs, and 4,5-epoxy-N-acetylsphingosine, an artificial epoxidation product of sphingolipids, to a porcine liver homogenate and human microsomes: Homogenization activates the same enzymes (Wills, 1966; Herold and Spiteller, 1996) which are stimulated by cell injury, for in stance in diseases connected with inflammation. The results of these investigations are reported in this paper.
Preparation o f 12,13-epoxy-l 1 -hydroxy-9-octadecenoic acid 13-Hydroperoxy-9,ll-octadecadienoic acid was prepared by action of soybean lipoxygenase on li noleic acid (Hamberg and Samuelsson, 1967) . The raw 13-hydroperoxy-9,ll-octadecenoic acid was purified by twofold normal phase NP-HPLC (Gallasch, 1998) .
The purified 13-HPODE was decomposed by treatm ent with Fe2+ ions (G ardner and Kleiman, 1981; Spiteller and Spiteller, 1998 ) to a great number of products, which were separated by NP-HPLC. Fractions were collected, trimethylsilylated with MSTFA and subjected to GC/MS. The frac tion thus identified to contain 12,13-epoxy-ll-hydroxy-9-octadecenoic acid was collected and repurified by RP-HPLC.
Incubation o f 12,13-epoxy-l 1 -hydroxy-9-octadecenoic acid with porcine liver homogenate
Fresh porcine liver hom ogenate was then incu bated with one diastereom er of the obtained puri fied 12,13-epoxy-ll-hydroxy-9-octadecenoic acid. Lipids were extracted according to Bligh and Dyer (1959) . The lipid fraction was trimethylsilylated and investigated by GC/MS. The GC indicated the presence of two main products, which according to their mass spectra represent a mixture of two diastereomeric trimethylsilylated 11,12,13-trihydroxy-9-octadecenoic acids in a ratio of about 13:10. This is expected by autocatalytic hydrolytic opening of the epoxide-ring of 12,13-epoxy-l 1-hydroxy-9-octadecenoic acid.
Incubation o f porcine liver homogenates with 4,5-epoxy-N-acetylsphingosine
4,5-epoxy-N-acetylsphingosine was prepared as recently described (M öllenberg and Spiteller, Fig. 1 . Part of the GC after incubation of 12,13-epoxyll-hydroxy-9-octadecenoic acid with liver homogenate (1, 2: diastereomers of ll,12,13-trihydroxy-9-octadecenoic acid) (RIC = recalculated ion current).
12,13-epoxy-11 -hydroxy-9-octadecenoic acid liver homogenate HO OH 11,12,13-trihydroxy-9-octadecenoic acid
Scheme 3. Ring opening of 12,13-epoxy-ll-hydroxy-9-octadecenoic acid in liver homogenate to diastereomeric ll,12,13-trihydroxy-9-octa-decenoic acid (1 + 2).
cine liver homogenate for 24 h the lipids were extracted, trimethylsilylated and investigated by GC/MS. The GC (Fig. 2 ) indicated besides un changed 4,5-epoxy-Ar-acetylsphingosine the pres ence of 4-/V-acetylamino-3-hydroxy-2-(l-hydroxytetradecyl)-l-oxa-cyclopentane (Möllenberg, 2000) and 4,5-dihydroxy-/V-acetylsphingosine (Polito et al., 1969 ) (see et al., Scheme 1). Peak 3 was tenta tively identified by its mass spectrum to be 4,5-epoxy-3-O-acetylsphingosine, formed by transfer of the acetyl group from the nitrogen to the adja cent hydroxyl group. The molecular mass of the com pound (identical with the mass of the isomeric 4,5-epoxy-/V-acetylsphingosine) was derived from the M-15 peak 486 to be 501. An intense peak at m /z 204 confirmed the presence of a H O C H 2 -CH=NHTM S+ fragment. Loss of 59 from the molecular mass indicates the presence of -O C O C H 3 in a-position of the carbon atom at tached to the nitrogen. In order to exclude the possibility of bacterial action within the liver tissue and possibly artificial generation of hydrolysis products of the added ep oxides, the incubation of 4,5-epoxy-/V-acetylsphingosine with liver hom ogenate was also car ried out with addition of antibiotics (neomycin, penicillin, streptomycin). The addition of antibiot ics showed no influence on the result, proving that bacterial action was not involved in the generation of the obtained products.
Incubation o f 12,13-epoxy-l 1 -hydroxy-9-octadecenoic acid and o f 4,5-epoxy-Nacetylsphingosine with human liver microsomes
In contrast to the reactions described above in cubation of 12,13-epoxy-l l-hydroxy-9-octadecenoic acid with human liver microsomes applying similar conditions as described for porcine liver (except for the reaction time of 3 h) the starting material was recovered nearly unchanged. Also in cubation of 4,5-epoxy-N-acetylsphingosine with human liver microsomes resulted mainly in recov ery of starting material, but to a small extent 4-/Vacetylamino-3-hydroxy-2-(l -hydroxytetradecyl)-1 -oxa-cyclopentane was formed. The diol resulting [RIC /", from ring opening of the epoxide was observed only in traces.
Discussion
Degradation of lipid hydroperoxides generated in the course of LPO is a multistep process not yet fully understood which is observed in all diseases combined with cell degradation (Spiteller, 1996) . LPO involves mainly linoleic acid (Spiteller, 2000) . Products obtained by opening of an epoxidering are rather common in nature: unsaturated com pounds, epoxidation products thereof and corre sponding diols were detected in plants, for in stance sterols (Meyer and Spiteller, 1997) or terpene derivatives (Ziegler, 1992) . Primary LPO products of linoleic acid are 9-and 13-HPODE. In order to elucidate the further fate of these com pounds pure 13-HPODE, generated enzymically by soybean lipoxygenase (Hamberg and Sam uelsson, 1967) , was subjected to artificial decom position by air oxidation induced by Fe2+ ions (G ardner and Kleiman, 1981; Spiteller and Spiteller, 1998) . Im portant products of this treat ment, also detected after artificial oxidation of low density lipoproteins (Spiteller, 2000) are epoxyhy droxy octadecenoic acids (Gardner and Kleiman, 1981) .
To elucidate the fate of epoxides in the body we isolated 12,13-epoxy-ll-hydroxy-9-octadecenoic acid from the product mixture obtained by treat ment of 13-HPODE with iron ions and incubated it with porcine liver homogenate. This resulted in opening of the epoxide ring and formation of two diastereom eric ll,12,13-trihydroxy-9-octadecenoic acids.
4,5-dihydroxylated derivatives of sphingosine have been reported to occur in biological tissue (Prostenik et al., 1982) . Therefore 4,5-epoxy-acetylsphingosine was prepared and subjected to treatm ent with liver homogenate as well. It re acted also by ring opening.
Microsomes represent a concentrated extract of liver enzymes. Thus we also expected ring opening of epoxides by addition of epoxides to m icro somes. In spite of addition of cofactors (NADPH, Mg ions) only traces of dihydroxy derivatives were observed. These results suggest -if not a special cofactor is involved -that transformation of epox ides to dihydroxyderivatives is not achieved in microsomes, possibly indicating that the necessary enzymes for transformation of epoxides to their corresponding diols are not located in the micro somes but in the cell membranes.
Experimental
Materials N-Methyl-./V-trimethylsilyltrifluoroacetamide (MSTFA) was obtained from Machery and Nagel (Düren, Germany). Solvents were distilled before use, water was distilled twice. Sphingosine was purchased from BIOM OL (Hamburg, Germany), reagents of analytical grade were bought from FLUKA AG (Buchs, Switzerland). Fresh porcine liver tissue was obtained from Dr. Brunnbauer, (slaughterhouse Bayreuth). Human liver micro somes were obtained from GENTEST C orpora tion (W oburn, USA).
Preparation o f 12,13-epoxy-l 1 -hydroxy-9-octadecenoic acid by conversion o f 13-HPODE
13-Hydroperoxyoctadecadienoic acid (13-H P O D E ) was synthesized according to Hamberg and Samuelsson (1967) . Raw 13-HPODE was purified twice by NP-HPLC (detection at 212 and 234 nm) on a Bischoff Ultrasep column: Isocratic separation 76 % A (A: n-hexane/AcOH 100/0.1, v/v) and 24 % B (B: n-hexane/isopropanol/AcOH 95/5/0.1, v/v/v) at 20 ml/min. Retention time: 17.0 min.
13-HPODE (181 mg, 580 jimol) was emulsified in 0.1 m phosphate buffer (266 ml, pH 7.4) and 543 ml 0.2 m KCl (KC1 solution prevents the 13-H P O D E to form micelles) by sonification. Oxida tion was started by addition of 1 m M F e S 0 4 (36 ml) and vitamin C (176 mg, 1 mmol), which keeps the iron ions in the oxidation state +2. The reaction mixture was stirred for 24 h at 37 °C . Purification of 12,13-epoxy-ll-hydroxy-9-octadecenoic acid was perform ed by NP-HPLC (detection at 212 nm) on the same column and with the same solvent mix ture as described above for 13-HPODE. 
Synthesis o f 4,5-epoxy-N-acetylsphingosine
Synthesis of 4,5-epoxy-vV-acetylsphingosine was carried out as recently described (Möllenberg and Spiteller, 2000) .
Incubation o f epoxides with liver homogenate
Fresh porcine liver tissue (10.6 g) was cut in small pieces, 40 m M TRIS/HC1 buffer (100 ml, pH 7.4) was added. The mixture was homogenized in a mixer (Waring Blendor) for 2 min. In order to decrease viscosity, a 5 ml portion of the homoge nate was diluted with 3 ml buffer. 1,8 mg of 12,13-epoxy-l l-hydroxy-9-octadecenoic acid deposited in a flask were added to the liver homogenate and the mixture was stirred at 37 °C for 24 h. The lipids were extracted according to Bligh and Dyer (1959) , converted to the TMS-derivatives and sub jected to GC/MS.
In the same m anner iV-acetylsphingosine (1 . 8 mg in 1 ml buffer) was incubated and pro cessed.
Incubation o f epoxides with human liver microsomes (HLM)
Commercially available HLM contain 10 mg to tal protein in 500 jil 250 mM sucrose. The system is recom m ended to be used with 1.3 mM NADPH and 3.3 mM MgCl2 (G entest Corporation, 1997) . A solution containing 10 ml TRIS/HC1 (40 m M , pH 7.4) MgCl2 • 6 H 20 (6.7 mg, 3.3 mM) and N A D PH (10.8 mg, 1.3 mM) was prepared. This so lution was divided into five portions and to each 2 ml 100 p,l of the thawed HML solution were added.
12,13-epoxy-l l-hydroxy-9-octadecenoic acid (1.4 mg, 4.5 jim ) was added to one portion of HLM and after addition of 2 ml H20 (to decrease the viscosity of the solution) the reaction mixture was stirred at 37 °C for 3 h. N-acetylsphingosine (1.4 mg, 4 (im ) was added to the next portion of HLM and treated as described for 12,13-epoxy-l 1-hydroxy-9-octadecenoic acid. The lipids were ex tracted according to Bligh and Dyer (1959) , con verted to the TMS-derivatives and subjected to GC/MS.
